Navigation Links
Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee
Date:9/8/2010

F Trap) with common chemotherapy regimens in several types of cancer.  In addition to VELOUR, the program includes two Phase 3 trials and one Phase 2 trial, all of which are fully enrolled:

  • VITAL study: 2nd-line treatment for metastatic non-small cell lung cancer in combination with docetaxel (Phase 3). Complete results are anticipated in the first half of 2011.  
  • VENICE study: 1st-line treatment for hormone-refractory metastatic prostate cancer (mHRPC) in combination with docetaxel and prednisone (Phase 3). An interim analysis is expected to be conducted by an IDMC in mid-2011, with complete results anticipated in 2012.
  • AFFIRM study: 1st-line treatment in mCRC in combination with folinic acid (leucovorin), 5-fluorouracil, and oxaliplatin (FOLFOX) (Phase 2).  Results are anticipated in 2H 2011.

  • About Aflibercept Aflibercept (VEGF Trap) is an anti-angiogenesis inhibitor with a unique mechanism of action.  This fusion protein binds all forms of Vascular Endothelial Growth Factor-A (VEGF-A), as well as VEGF-B and placental growth factor (PIGF), additional angiogenic growth factors that appear to play a role in tumor angiogenesis and inflammation. Aflibercept has been shown to bind VEGF-A, VEGF-B, and PlGF with higher affinity than their natural receptors.

    About Colorectal Cancer Worldwide, colorectal cancer is the third most common cancer in men and the second in women; accounting for about 8% of all cancer deaths, making it the fourth most common cause of death from cancer.  Colorectal cancer disproportionately affects people over age 65.  FOLFIRI (5-fluorouracil, leucovorin, and irinotecan) is considered a standard backbone of second-line treatment in patients with advanced metastatic colorectal cancer.

    About sanofi-aventis OncologySanofi-aventis Oncology is targeting cancer on all fronts in an effort to address unmet medical needs for a broad range of patie
    '/>"/>

    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
    4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
    5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
    9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... September 19, 2014 According ... Type (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, ... Manifold, & Rotary) & Geography - Global Trends ... and segments the lyophilization market on the basis ... and projections of the market size of each ...
    (Date:9/19/2014)... 19, 2014  Lpath, Inc. (NASDAQ: ... therapeutics, announced today that it has entered into ... common stock and 3,605,042 unregistered warrants in a ... one registered share of common stock and one ... common stock will be $3.475.  The warrants have ...
    (Date:9/19/2014)... -- Aufgrund der enormen Nachfrage seines ... aktualisiert, der jetzt auch die Jahre 2014 - ... pharmaserialisation.com , zeigt die Serialisierungsanforderungen weltweit und den ... Für international tätige Unternehmen geht es ... sondern darum, "wann" sie die neu in Kraft ...
    Breaking Medicine Technology:Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2
    ... N.Y.--(BUSINESS WIRE)--Mar 7, 2007 - Advanced Viral,Research Corp. ... that new information on AVR118 has been,accepted for ... of Clinical Oncology (ASCO) Abstract publication. This,publication will ... will be attending this year's meeting in Chicago ...
    ... will be presented at the American College of,Cardiology's ... 2007 /PRNewswire-FirstCall/ -- CV,Therapeutics, Inc. announced today that ... study of ranolazine shows there was no,adverse trend ... study did not meet the primary efficacy endpoint. ...
    Cached Medicine Technology:American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 2American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 3CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3
    (Date:9/20/2014)... Mexico (PRWEB) September 20, 2014 The ... including Villa del Palmar Cabo San Lucas, Villa La ... relation to Hurricane Odile, with plans to welcome guests ... , As of Sept. 19, all members and guests ... home, thanks to a coordinated effort with government authorities. ...
    (Date:9/20/2014)... 2014 Ticket Down is a ... This popular ticket exchange is offering their customer appreciation ... nearing that next step in the entertainment business. The 21-year-old ... the music and entertainment business, but is closing in on ... No. 1 album, will hit the road next year on ...
    (Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new blog post explaining the ... provides for vulnerable family members. , Providing financial ... priority for every provider. It is now possible to ... visiting a doctor. , Life insurance plans that ... to $300,000, but only to healthy applicants. Clients who ...
    (Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... Ariana Grande concert tickets for her 2015 “Honeymoon ... appreciation promo code ARIANA-2015 for added savings. , In early ... the biggest stars in the world across North America. Twenty-one-year-old ... the “Honeymoon Tour,” which will take her to 25 cities ...
    (Date:9/20/2014)... Recently, Best Cheap Hosting USA ... its new website. The new site provides the ... products for customers. Here, people can find a ... decision. Also, it has recommended some excellent web ... of the great web hosting suppliers, InMotion ( ...
    Breaking Medicine News(10 mins):Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2
    ... less health conscious and may be spending less time daily ... that working full time leads to a sedentary life style ... work full time have less time for leisure, which is ... in front of the computer. These seem to be the ...
    ... Clopidogrel and aspirin is more effective than only aspirin//., ... four countries of the Europe were given the combination ... the study had had a stroke or transient ischemic ... narrower carotid arteries. The experimental group had microscopic blood ...
    ... say cholesterol may be actually needed to help insulate the ... that too much of it could end up in // ... up as plaque and can cause heart attacks and strokes. ... blame for the build-up. ACAT2 is one of four enzymes ...
    ... way the final fetal head position is going to be.//, ... and delivery. This is a form of painkiller that is ... pelvic muscles and nerves get the anesthetic medication. The lady ... longer be in pain. ,A study was conducted ...
    ... of menopausal symptoms. However if this is used in// conjunction ... be altered. ,Scientists of Yale School of Medicine in ... medication taken by breast cancer patients may alter the way ... not even aware of the fact that their patients may ...
    ... starts on its immunity system to fight the infection.// ... infections are fought by the human immunity system. A ... of Medicine had identified a molecule that triggers the ... caused by the parasite. ,A parasite called Toxoplasma ...
    Cached Medicine News:
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: